Upadhyay Suketu's Insider Trades & SAST Disclosures
Upadhyay Suketu's most recent trade in Zimmer Biomet Holdings Inc was a trade of 4,560 Common Stock done . Disclosure was reported to the exchange on March 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Upadhyay Suketu.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 4,560 | 50,882 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 4,560 | 4,559 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.86 per share. | 06 Mar 2025 | 2,029 | 48,853 (0%) | 0% | 104.9 | 212,761 | Common Stock |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 19,090 | 19,090 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 5,446 | 10,890 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 5,446 | 48,745 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.46 per share. | 20 Feb 2025 | 2,423 | 46,322 (0%) | 0% | 103.5 | 250,684 | Common Stock |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 21,622 | 51,454 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 21,622 | 0 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 21,622 | 21,622 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.00 per share. | 14 Feb 2025 | 8,155 | 43,299 (0%) | 0% | 101 | 823,655 | Common Stock |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 15,948 | 0 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 15,948 | 15,948 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 15,948 | 36,842 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 108.48 per share. | 08 Nov 2024 | 7,097 | 29,745 (0%) | 0% | 108.5 | 769,883 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 1,168 | 1,403 | - | - | Deferred Stock Units | |
| Vertex Pharmaceuticals, Inc. | Suketu Upadhyay | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 May 2024 | 1,168 | 2,559 (0%) | 0% | - | Common Stock | |
| Vertex Pharmaceuticals, Inc. | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 1,001 | 3,727 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 4,561 | 9,119 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 4,561 | 22,683 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.82 per share. | 06 Mar 2024 | 1,919 | 20,764 (0%) | 0% | 125.8 | 241,449 | Common Stock |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2024 | 7,043 | 20,213 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Upadhyay Suketu | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2024 | 7,043 | 0 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Upadhyay Suketu | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.80 per share. | 25 Feb 2024 | 2,091 | 18,122 (0%) | 0% | 128.8 | 269,321 | Common Stock |
| Zimmer Biomet Holdings Inc | Upadhyay Suketu | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 16,336 | 16,336 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 3,768 | 14,660 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 3,768 | 0 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 146.51 per share. | 01 Jul 2023 | 1,677 | 12,983 (0%) | 0% | 146.5 | 245,697 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 1,168 | 2,726 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 13,680 | 13,680 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 3,860 | 0 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 3,860 | 12,047 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 124.73 per share. | 21 Feb 2023 | 1,155 | 10,892 (0%) | 0% | 124.7 | 144,063 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 96 | 235 | - | - | Deferred Stock Units | |
| Vertex Pharmaceuticals, Inc. | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2022 | 96 | 138 | - | - | Deferred Stock Units | |
| Vertex Pharmaceuticals, Inc. | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 41 | 41 | - | - | Deferred Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 3,768 | 9,231 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 3,768 | 3,768 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.85 per share. | 01 Jul 2022 | 1,249 | 7,982 (0%) | 0% | 105.9 | 132,207 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 1,558 | 1,558 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 6,831 | 6,831 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 3,744 | 3,744 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 50,046 | 50,046 | - | - | Employee Stock Option (right to buy) | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 3,655 | 6,416 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 3,655 | 7,310 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.94 per share. | 01 Jul 2021 | 1,112 | 5,304 (0%) | 0% | 161.9 | 180,077 | Common Stock |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 33,914 | 33,914 | - | - | Employee Stock Option (right to buy) | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 3,655 | 3,655 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 3,655 | 10,965 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 119.21 per share. | 01 Jul 2020 | 1,079 | 2,576 (0%) | 0% | 119.2 | 128,628 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges